收藏切换
Impact of Shenqi Gankang tablets on clinical efficacy and immune function in the treatment of chronic hepatitis B
收藏切换
Xiaoxia WEI, Shupeng DUAN, Bin ZHU*
World Clinical Drug | 2022, 43(7) : 868 - 872
Less
收藏切换
World Clinical Drug | 2022, 43(7): 868-872
• Article •
Impact of Shenqi Gankang tablets on clinical efficacy and immune function in the treatment of chronic hepatitis B
Full
Xiaoxia WEI, Shupeng DUAN, Bin ZHU*
Affiliations
  • Department of Infectious Diseases, the First Affiliated Hospital of Xinxiang Medical University, Weihui 453199, Henan Province, China
Published: 2022-07-10 doi: 10.13683/j.wph.2022.07.010
Outline
收藏切换
Objective

To investigate the impact of Shenqi Gankang tablets on clinical efficacy and immune function in the treatment of chronic hepatitis B (CHB).

Methods

A total of 182 patients with CHB from Department of Infectious Diseases, the First Affiliated Hospital of Xinxiang Medical University between January 2017 to December 2019 were collected. All patients were randomly divided into control group (n=91) and observation group (n=91). The control group was given entecavir maleate tablets, 0.5 mg/time, one time/d and the observation group was additional given Shenqi Gankang tablets, 2.1 g/time, 3 times/d on the basis of the control group. Two groups were treated for 6 months. The differences of clinical efficacy, liver function index (AST、ALT), liver fibrosis index (LN、HA、PCⅢ, Ⅳ-C), T lymphocyte subsets index (CD4+, CD8+, CD4+/CD8+), cytokine levels index (IFN-γ, IL-2, IL-4, IL-10) and incidence of adverse reactions between two groups were compared after treatment.

Results

The total effective rates in the observation group was significantly higher than control group (P=0.014). After treatment, the ALT, AST, LN, HA, PCⅢ, Ⅳ-C, CD8+ cells, IL-4, IL-10 of two groups were significantly reduced, while CD4+ cells, CD4+/CD8+ ratio value, IFN-γ, IL-2 were significantly increased, with statistically significant differences between two groups before and after treatment (P<0.05). After treatment, the ALT, AST, LN, HA, PCⅢ, Ⅳ-C, CD8+ cells, IL-4, IL-10 of the observation group were significantly lower than that of the control group, while CD4+ cells, CD4+/CD8+ ratio value, IFN-γ, IL-2 were higher than that of the control group, with statistically significant differences (P<0.05). The incidence of adverse reactions in control and observation group was 13.19% and 12.08%, respectively. There was no significant difference between the two groups (P=0.823).

Conclusion

Shenqi Gankang tablet is safe and effective in the treatment of CHB, and it could significantly improve liver function and alleviate the degree of liver fibrosis. Shenqi Gankang tablet can also promote Th1 cell immune response and enhance immune function.

chronic hepatitis B  /  Shenqi Gankang tablet  /  liver function  /  liver fibrosis  /  T lymphocyte  /  clinical efficacy  /  adverse reaction
魏晓霞, 段树鹏, 朱斌. 参芪肝康片对慢性乙型肝炎患者的疗效及免疫功能的影响. 世界临床药物, 2022 , 43 (7) : 868 -872 . DOI: 10.13683/j.wph.2022.07.010
Xiaoxia WEI, Shupeng DUAN, Bin ZHU. Impact of Shenqi Gankang tablets on clinical efficacy and immune function in the treatment of chronic hepatitis B[J]. World Clinical Drug, 2022 , 43 (7) : 868 -872 . DOI: 10.13683/j.wph.2022.07.010
Year 2022 volume 43 Issue 7
14
5
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.07.010
  • Receive Date:2022-03-08
  • Online Date:2026-11-19
  • Published:2022-07-10
Article Data
Affiliations
History
  • Received:2022-03-08
Affiliations
    Department of Infectious Diseases, the First Affiliated Hospital of Xinxiang Medical University, Weihui 453199, Henan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.07.010
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT